Issue link: https://beckershealthcare.uberflip.com/i/849019
20 DEVICES & IMPLANTS 10 Orthopedic Device Company CEOs: Who is Paid the Most? By Laura Dyrda O rthopedic and spine device company leader compensation varies across the board based on the company's size and market share. While some have a larger base salary, others have higher bonus and stock option value. Here is the compensation for 10 ortho- pedic and spine device company leaders based on data from Salary.com. e in- formation is reported according to the proxy statements filed for the 2015 fiscal year. 1. Alex Gorsky. Chairman and CEO of Johnson & Johnson: $21.2 million 2. Omar Ishrak. Chairman and CEO of Medtronic PLC: $15 million 3. Kevin Lobo. Chairman, President and CEO of Stryker: $12.8 million 4. David Dvorak. President and CEO of Zimmer Biomet: $10.6 million 5. Gregory T. Lucier. Chairman and CEO of NuVasive: $6 million 6. Bradley R. Mason. President and CEO of Orthofix: $3.5 million 7. Olivier Bohuon. CEO of Smith & Nephew: $3.3 million* 8. Eric Major. President and CEO of K2M: $2.8 million 9. David Mowry. President, CEO and Executive Director of Wright Medical Group: $2.3 million 10. Anthony Williams. President of Glo- bus Medical: $1.9 million *Indicates information provided by e Telegraph for 2016 compensation. n Johnson & Johnson, US Defense Dept. Reach $260M Deal on Orthopedic Devices — 4 Takeaways By Adam Schrag Johnson & Johnson was awarded a contract to supply the U.S. Defense Depart- ment with orthopedic devices, according to Mass Device. Here are four things to know: 1. The one-year contract includes four additional one-year options. 2. The agreement's total maximum value is roughly $260.5 million. 3. Johnson & Johnson will supply the Army, Navy, Air Force, Marine Corps and federal civilian agencies with orthopedic products. 4. The agreement took place on Sat., April 27, 2017, and will expire on April 27, 2022. n 5 Trends in the US Minimally Invasive Spinal Implant Market — NuVasive Leads the Way By Laura Dyrda iData Research reports Medtronic and NuVasive are leading the U.S. minimally in- vasive spine implant market. "Growth in the minimally invasive spinal implant market is largely driven by the ad- vantages of minimally invasive surgery over open surgery; these include reduced trauma, shorter hospital stays, lower postoperative medication and earlier return to work," said Jeffrey Wong, a strategic analyst manager at iData Research. "However, growth is expected to slow as a result of the increasing penetration of MIS proce- dures into the traditional fusion market and growing motion preservation market." The key trends in the report include: 1. A shift toward oblique lumbar interbody fusion and lateral lumbar interbody fusion while the market moves away from minimally invasive posterior lumbar in- terbody fusion and transforaminal lumbar interbody fusion devices. 2. SI-Bone's iFuse Implant System is the fastest growing implant segment in the minimally invasive sacroiliac joint fusion market, which has grown rapidly since re- imbursement policy changed for the procedure. The market is expected to stabi- lize in the coming years. 3. NuVasive leads the U.S. minimally invasive spine market in the interbody device, pedicle screw, spinous process fixation and facet fixation segments. 4. Medtronic is the second leading company in the minimally invasive spine device market driven by the minimal access spine technology systems including METRx and CD Horizon systems. The company's spinal products also include minimally invasive non-fusion procedures like X-Stop and Kyphon. 5. The other major competitors in the market are DePuy Synthes, Globus Medical, Stryker, K2M and Richard Wolf. n